help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Endocrinology, doi:10.1210/en.2003-1498
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
145/6/2824    most recent
Author Manuscript (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Miquet, J. G.
Right arrow Articles by Turyn, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Miquet, J. G.
Right arrow Articles by Turyn, D.
Endocrinology Vol. 145, No. 6 2824-2832
Copyright © 2004 by The Endocrine Society

Suppression of Growth Hormone (GH) Janus Tyrosine Kinase 2/Signal Transducer and Activator of Transcription 5 Signaling Pathway in Transgenic Mice Overexpressing Bovine GH

Johanna G. Miquet, Ana I. Sotelo, Andrzej Bartke and Daniel Turyn

Instituto de Química y Fisicoquímica Biológicas (University of Buenos Aires-Consejo Nacional de Investigaciones Científicas y Técnicas) (J.G.M., A.I.S., D.T.), Facultad de Farmacia y Bioquímica, Junín 956 (1113) Buenos Aires, Argentina; and Department of Geriatrics (A.B.), School of Medicine, Southern Illinois University, Springfield, Illinois

Address all correspondence and requests for reprints to: Dr. Daniel Turyn, Departamento de Química Biológica, Facultad de Farmacia y Bioquímica, Universidad de Buenos Aires, Junín 956 (1113) Buenos Aires, Argentina. E-mail: dturyn{at}qb.ffyb.uba.ar.

High continuous GH levels in vivo produce desensitization of the Janus tyrosine kinase 2 (JAK2)/signal transducer and activator of transcription 5 (STAT5) pathway of GH signaling in the liver. To evaluate the mechanisms involved in this desensitization, transgenic mice overexpressing bovine GH were used. In these animals, GH receptor and membrane-associated JAK2 kinase are increased 4.5- and 6-fold, respectively. However, JAK2. STAT5a and –5b do not become tyrosine phosphorylated in response to GH stimulus, nor are these STAT proteins recruited to membranes, suggesting that they cannot bind to the receptor. The content of the suppressor cytokine-inducible src homology 2 (SH2)-containing protein (CIS), both total and membrane-associated, is markedly increased in the liver of GH transgenic mice. This could account for the inhibition of STAT5 activation, because CIS competes with STAT5 for GH receptor docking sites. Existence of an alternative mechanism of negative regulation of this signaling pathway by chronically elevated GH levels is suggested by the low level of JAK2 phosphorylation that transgenic mice exhibit. Whereas total SH2-containing phosphatase 2 (SHP-2) content is the same in both kinds of mice, membrane-associated SHP-2 protein levels increase 4.5-fold in GH transgenic animals. This could explain the dramatic inhibition of JAK2 phosphotyrosine level, thus contributing to the suppression of GH signaling observed in these transgenic mice.




This article has been cited by other articles:


Home page
EndocrinologyHome page
Z. Wang, M. M. Masternak, K. A. Al-Regaiey, and A. Bartke
Adipocytokines and the Regulation of Lipid Metabolism in Growth Hormone Transgenic and Calorie-Restricted Mice
Endocrinology, June 1, 2007; 148(6): 2845 - 2853.
[Abstract] [Full Text] [PDF]


Home page
J Mol EndocrinolHome page
M. L Rise, S. E Douglas, D. Sakhrani, J. Williams, K V. Ewart, M. Rise, W. S Davidson, B. F Koop, and R. H Devlin
Multiple microarray platforms utilized for hepatic gene expression profiling of GH transgenic coho salmon with and without ration restriction.
J. Mol. Endocrinol., October 1, 2006; 37(2): 259 - 282.
[Abstract] [Full Text] [PDF]


Home page
J EndocrinolHome page
J G Miquet, A I Sotelo, F P Dominici, M S Bonkowski, A Bartke, and D Turyn
Increased sensitivity to GH in liver of Ames dwarf (Prop1df/Prop1df) mice related to diminished CIS abundance
J. Endocrinol., December 1, 2005; 187(3): 387 - 397.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
T. Landsman and D. J. Waxman
Role of the Cytokine-induced SH2 Domain-containing Protein CIS in Growth Hormone Receptor Internalization
J. Biol. Chem., November 11, 2005; 280(45): 37471 - 37480.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
J. G. Miquet, A. I. Sotelo, A. Bartke, and D. Turyn
Desensitization of the JAK2/STAT5 GH signaling pathway associated with increased CIS protein content in liver of pregnant mice
Am J Physiol Endocrinol Metab, October 1, 2005; 289(4): E600 - E607.
[Abstract] [Full Text] [PDF]


Home page
J EndocrinolHome page
J G Miquet, A I Sotelo, A Bartke, and D Turyn
Increased SH2-B{beta} content and membrane association in transgenic mice overexpressing GH
J. Endocrinol., May 1, 2005; 185(2): 301 - 306.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2004 by The Endocrine Society